Optimizing the implementation of future treatment using surrogate end-points

Breast Cancer Res. 2008;10 Suppl 4(Suppl 4):S26. doi: 10.1186/bcr2186. Epub 2008 Dec 18.
No abstract available

MeSH terms

  • Biomarkers / analysis*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / therapy*
  • Cell Proliferation
  • Clinical Trials as Topic
  • Female
  • Humans
  • Ki-67 Antigen / metabolism

Substances

  • Biomarkers
  • Ki-67 Antigen